Clinical Trial Update: Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial (Gator SCALES-WHF) is evaluating subcutaneous Lasix (furosemide) to relieve symptoms of worsening heart failure due to volume overlo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Lasix (furosemide)

Snippet

Sponsor: University of Florida | Conditions: Heart Failure, Volume Overload | Phase 4 | Status: RECRUITING